Filing Details

Accession Number:
0001062993-22-008073
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-17 17:33:08
Reporting Period:
2022-03-15
Accepted Time:
2022-03-17 17:33:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588972 Recro Pharma Inc. REPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201526 Jr David J Enloe C/O Recro Pharma, Inc.
1 E. Uwchlan Ave, Suite 112
Exton PA 19341
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-15 512 $1.96 524,879 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.